← Back to Search

Resistance Training + Protein for Stroke Recovery (REPS Trial)

N/A
Recruiting
Led By Alice S. Ryan, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Completion of all regular post-stroke physical therapy
Able to walk 10 meters without human assistance
Must not have
Cardiac history of: a) unstable angina, b) recent (less than 3 months prior to study entry) myocardial infarction, congestive heart failure (NYHA category II-IV); c) hemodynamically significant valvular dysfunction
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and after the 3 month intervention

Summary

This trial will compare the effects of resistive training with or without protein supplementation in people who have suffered a stroke.

Who is the study for?
This trial is for stroke survivors who've had a stroke over 3 months ago, finished all regular post-stroke therapy, can walk 10 meters unassisted, and have the cognitive ability to consent and participate. It's not for those doing regular exercise, heavy drinkers, with certain neurological/cardiac conditions or severe medical issues that could affect participation.
What is being tested?
The study tests if adding protein supplements to resistive training helps muscle growth more than just training with a placebo in chronic stroke patients. Participants will be randomly assigned to receive either protein or placebo after their exercise sessions.
What are the potential side effects?
Potential side effects may include digestive discomfort from the protein supplement and typical risks associated with resistance training such as muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have finished all my scheduled physical therapy sessions after my stroke.
Select...
I can walk 10 meters by myself.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a recent history of serious heart issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and after the 3 month intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and after the 3 month intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in thigh muscle area
Secondary study objectives
Change in functional mobility (6 min walk distance)
Change in muscle strength
Change in myostatin messenger RNA (mRNA) level

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Resistive Training + ProteinExperimental Treatment1 Intervention
Participants will drink 30 grams of whey protein after each resistance training session.
Group II: Resistive TrainingPlacebo Group1 Intervention
Participants will drink a placebo beverage after each resistance training session.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,659 Total Patients Enrolled
86 Trials studying Stroke
6,730 Patients Enrolled for Stroke
Baltimore VA Medical CenterFED
32 Previous Clinical Trials
2,945 Total Patients Enrolled
5 Trials studying Stroke
702 Patients Enrolled for Stroke
Alice S. Ryan, PhDPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
6 Previous Clinical Trials
581 Total Patients Enrolled
1 Trials studying Stroke
98 Patients Enrolled for Stroke

Media Library

Resistive Training Clinical Trial Eligibility Overview. Trial Name: NCT02347995 — N/A
Stroke Research Study Groups: Resistive Training + Protein, Resistive Training
Stroke Clinical Trial 2023: Resistive Training Highlights & Side Effects. Trial Name: NCT02347995 — N/A
Resistive Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT02347995 — N/A
~0 spots leftby Dec 2024